French Parliament Public Hearing on Biosimilar Medicines, Paris, 29 January 2015 – Intervention from EMA Spokesperson Camille Vleminckx

OPEN LETTER: Members of the European Parliament and EU 27… 8 November 2023 Medicines for Europe, the European association representing generic, biosimilar and…
Parliament compromise on pharmaceutical legislation… 19 March 2024 Today, the Members of the Parliament’s health committee (ENVI) adopted…
Essential medicines must be included in EU industrial policy… 3 March 2022 Political ambitions to strengthen EU supply chain resilience following the…
A step forward for the secure supply of medicines and… 25 October 2023 The off-patent medicines industry provides 70% of medicines dispensed to…